![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Isf 2522
2. Isf-2522
1. 62613-82-5
2. 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide
3. 4-hydroxy-2-oxopyrrolidine-n-acetamide
4. Isf 2522
5. Cgp 21690e
6. 1-pyrrolidineacetamide, 4-hydroxy-2-oxo-
7. 4-hydroxy-2-oxo-1-pyrrolidineacetamide
8. (+-)-oxiracetam
9. Isf-2522
10. Ct-848
11. Cgp-21690e
12. Oxiracetam(random Configuration)
13. Gnf-pf-1005
14. Hydroxypiracetam
15. Neuromet
16. (+-)-4-hydroxy-2-oxo-1-pyrrolidineacetamide
17. Oxiracetam (inn)
18. 1-pyrrolidineacetamide, 4-hydroxy-2-oxo-, (+-)-
19. P7u817352g
20. Ncgc00015768-02
21. Neuractiv
22. (r)-(+)-oxiracetam
23. Oxiracetam [inn]
24. 4-hydroxypiracetam
25. Oxiracetamum
26. Oxiracetamum [inn-latin]
27. Ccris 4221
28. Oxiracetam [inn:ban]
29. Brn 1529719
30. Oxiractam
31. Oriest
32. Unii-p7u817352g
33. Mfcd00242951
34. Oxiracetam [mi]
35. Oxiracetam [jan]
36. Oxiracetam [mart.]
37. Dsstox_cid_25180
38. Dsstox_rid_80728
39. Oxiracetam [who-dd]
40. Dsstox_gsid_45180
41. Lopac0_000933
42. Chembl36633
43. Schembl526050
44. Dtxsid9045180
45. Amy5769
46. Isf2522
47. Chebi:134788
48. Hms3262l08
49. Hms3652j06
50. Hms3885b17
51. Act04730
52. Bcp06209
53. Bcp31146
54. Hy-b1715
55. Tox21_110218
56. Tox21_500933
57. Ac-670
58. Cs3412
59. S4270
60. Akos013252523
61. Ab05478
62. Ccg-205014
63. Cs-8012
64. Db13601
65. Lp00933
66. Sdccgsbi-0050907.p002
67. 4- Hydroxy-2-oxopyrrolidine-n-acetamide
68. 4-hydroxypyrrolidin-2-on-1-yl Acetamide
69. Ncgc00015768-03
70. Ncgc00015768-04
71. Ncgc00015768-07
72. Ncgc00094242-01
73. Ncgc00094242-02
74. Ncgc00261618-01
75. 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide
76. 68567-97-5
77. As-11801
78. 4-hydroxy-2-oxo-pyrrolidinacetamide
79. Cas-62613-82-5
80. Db-054213
81. Eu-0100933
82. Ft-0630731
83. Ft-0673341
84. Ft-0673343
85. O0398
86. Sw220157-1
87. 2-(4-hydroxypyrrolidin-2-on-1-yl) Acetamide
88. En300-75437
89. A21970
90. D07346
91. O 3011
92. 613o825
93. A861378
94. Q415099
95. Sr-01000076046
96. Q-201526
97. Sr-01000076046-1
98. 2-(4-hydroxy-2-oxo-1-pyrrolidinyl)acetamide
99. R-oxiracetam; (r)-isf-2522;(r)-(+)-oxiracetam
100. Z1259086528
Molecular Weight | 158.16 g/mol |
---|---|
Molecular Formula | C6H10N2O3 |
XLogP3 | -2.2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 158.06914219 g/mol |
Monoisotopic Mass | 158.06914219 g/mol |
Topological Polar Surface Area | 83.6 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 192 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Psychotropic Drugs
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX07 - Oxiracetam